bondronat 2mg2ml concentrate for solution for infusion vials
atnahs pharma uk ltd - ibandronic sodium monohydrate - solution for infusion - 1mg/1ml
bonviva 150 mg f.c. tablets film-coated tablet
atnahs pharma uk limited, united kingdom - ibandronic acid - film-coated tablet - 150 mg
bonviva 150 mg film-coated tablet
atnahs pharma uk ltd.; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - ibandronic acid - film-coated tablet - 150 mg
bonviva 150 mg f.c. tablets film-coated tablet
atnahs pharma uk limited, united kingdom - ibandronic acid - film-coated tablet - 150 mg
bonviva 150 mg f.c. tablets
atnahs pharma uk limited, united kingdom - ibandronic acid - tablet - 150 mg
dipentum 250mg capsules
atnahs pharma australia pty ltd - olsalazine sodium, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; gelatin; magnesium stearate; caramel; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified water; industrial methylated spirit; ammonia - indications as at 19 december 2000: treatment of ulcerative colitis in patients intolerant of sulphasalazine.
naprosyn ec 500mg gastro-resistant tablets
atnahs pharma uk limited - naproxen - gastro-resistant tablet - 500 milligram(s) - propionic acid derivatives; naproxen - anti-inflammatory and antirheumatic products, non- steroids - naprosyn ec is indicated in adults and adolescents (16 years and above) for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculo-skeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea.
naprosyn ec 250mg gastro-resistant tablets
atnahs pharma uk limited - naproxen - gastro-resistant tablet - 250 milligram(s) - propionic acid derivatives; naproxen - anti-inflammatory and antirheumatic products, non- steroids - naprosyn ec is indicated in adults and adolescents (16 years and above) for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculo-skeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea.
kytril
atnahs pharma uk limited - granisetron hydrochloride - solution for injection - 1 mg/ml - granisetron
kytril
atnahs pharma uk limited - granisetron hydrochloride - solution for injection - 3 mg/ml - granisetron